Risks and benefits of vaccinia-vectored vaccine from the regulatory perspective.
Marcus-Sekura
C J
CJ
Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892.
Quinnan
G V
GV
D000818:Animals; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005822:Genetic Vectors; D006801:Humans; D014612:Vaccines / Q000592:standards*; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000592:standards*; D014616:Vaccinia virus; D014765:Viral Vaccines / Q000009:adverse effects / Q000592:standards*
D014612:Vaccines; D014614:Vaccines, Synthetic; D014765:Viral Vaccines